Detection of farnesyltransferase interface hot spots through computational alanine scanning mutagenesis.

作者: Marta AS Perez , Sérgio F Sousa , Eduardo FT Oliveira , Pedro A Fernandes , Maria J Ramos

DOI: 10.1021/JP205481Y

关键词:

摘要: In this study, we present a detailed characterization of the full α/β interface in farnesyltransferase (FTase) enzyme, an important target drug design efforts. This is presented terms hot spots, warm and null spots based on application improved variation computational alanine scanning mutagenesis methodology, complemented with extensive solvent-accessible surface area interfacial hydrogen-bonding analysis. A total 130 amino acid residues were considered analysis, number that represents 16.0% 814 enzyme. Globally, results provide clues most structural energetic determinants for dimer formation, suggesting several key targets at subunit development new molecules aim to inhibit FTase activity through blocking formation fully active dimer, yielding useful indications future

参考文章(139)
Deema Hussein, Stephen S. Taylor, Farnesylation of Cenp-F is required for G2/M progression and degradation after mitosis. Journal of Cell Science. ,vol. 115, pp. 3403- 3414 ,(2002) , 10.1242/JCS.115.17.3403
Irina Massova, Peter A. Kollman, Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding Perspectives in Drug Discovery and Design. ,vol. 18, pp. 113- 135 ,(2000) , 10.1023/A:1008763014207
Johan Åqvist, Carmen Medina, Jan-Erik Samuelsson, A New Method for Predicting Binding Affinity in Computer-Aided Drug Design Protein Engineering. ,vol. 7, pp. 385- 391 ,(1994) , 10.1093/PROTEIN/7.3.385
Y. Reiss, M.C. Seabra, S.A. Armstrong, C.A. Slaughter, J.L. Goldstein, M.S. Brown, Nonidentical subunits of p21H-ras farnesyltransferase. Peptide binding and farnesyl pyrophosphate carrier functions. Journal of Biological Chemistry. ,vol. 266, pp. 10672- 10677 ,(1991) , 10.1016/S0021-9258(18)99276-8
Julia Head, Stephen RD Johnston, New targets for therapy in breast cancer: Farnesyltransferase inhibitors Breast Cancer Research. ,vol. 6, pp. 262- 268 ,(2004) , 10.1186/BCR947
P F Lebowitz, J P Davide, G C Prendergast, Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity. Molecular and Cellular Biology. ,vol. 15, pp. 6613- 6622 ,(1995) , 10.1128/MCB.15.12.6613
Frances C. Bernstein, Thomas F. Koetzle, Graheme J.B. Williams, Edgar F. Meyer, Michael D. Brice, John R. Rodgers, Olga Kennard, Takehiko Shimanouchi, Mitsuo Tasumi, The Protein Data Bank: a computer-based archival file for macromolecular structures. Journal of Molecular Biology. ,vol. 112, pp. 535- 542 ,(1977) , 10.1016/S0022-2836(77)80200-3
Nichole C. Crespo, Junko Ohkanda, Tim J. Yen, Andrew D. Hamilton, Saı̈d M. Sebti, The farnesyltransferase inhibitor, FTI-2153, blocks bipolar spindle formation and chromosome alignment and causes prometaphase accumulation during mitosis of human lung cancer cells. Journal of Biological Chemistry. ,vol. 276, pp. 16161- 16167 ,(2001) , 10.1074/JBC.M006213200
Katja Kohring, Jochen Wiesner, Mirko Altenkämper, Jacek Sakowski, Katrin Silber, Alexander Hillebrecht, Peter Haebel, Hans-Martin Dahse, Regina Ortmann, Hassan Jomaa, Gerhard Klebe, Martin Schlitzer, Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials. ChemMedChem. ,vol. 3, pp. 1217- 1231 ,(2008) , 10.1002/CMDC.200800043
Peter A. Kollman, Irina Massova, Carolina Reyes, Bernd Kuhn, Shuanghong Huo, Lillian Chong, Matthew Lee, Taisung Lee, Yong Duan, Wei Wang, Oreola Donini, Piotr Cieplak, Jaysharee Srinivasan, David A. Case, Thomas E. Cheatham, Calculating Structures and Free Energies of Complex Molecules:  Combining Molecular Mechanics and Continuum Models Accounts of Chemical Research. ,vol. 33, pp. 889- 897 ,(2000) , 10.1021/AR000033J